Bristol Myers Squibb Co. (BMY)
66.57
-0.38
(-0.57%)
USD |
NYSE |
Aug 28, 16:00
66.57
0.00 (0.00%)
After-Hours: 20:00
Bristol Myers Squibb Cash from Operations (Quarterly) : 3.393B for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.393B |
| March 31, 2026 | 1.104B |
| December 31, 2025 | 1.974B |
| September 30, 2025 | 6.311B |
| June 30, 2025 | 3.917B |
| March 31, 2025 | 1.954B |
| December 31, 2024 | 4.439B |
| September 30, 2024 | 5.591B |
| June 30, 2024 | 2.326B |
| March 31, 2024 | 2.834B |
| December 31, 2023 | 4.252B |
| September 30, 2023 | 4.751B |
| June 30, 2023 | 1.887B |
| March 31, 2023 | 2.97B |
| December 31, 2022 | 3.306B |
| September 30, 2022 | 3.687B |
| June 30, 2022 | 2.261B |
| March 31, 2022 | 3.812B |
| December 31, 2021 | 4.057B |
| September 30, 2021 | 5.266B |
| June 30, 2021 | 3.06B |
| March 31, 2021 | 3.824B |
| December 31, 2020 | 3.67B |
| September 30, 2020 | 2.219B |
| June 30, 2020 | 4.269B |
| Date | Value |
|---|---|
| March 31, 2020 | 3.894B |
| December 31, 2019 | 2.038B |
| September 30, 2019 | 2.556B |
| June 30, 2019 | 2.083B |
| March 31, 2019 | 1.39B |
| December 31, 2018 | 2.429B |
| September 30, 2018 | 1.279B |
| June 30, 2018 | 1.057B |
| March 31, 2018 | 1.175B |
| December 31, 2017 | 1.117B |
| September 30, 2017 | 1.713B |
| June 30, 2017 | 1.584B |
| March 31, 2017 | 861.00M |
| December 31, 2016 | 1.428B |
| September 30, 2016 | 1.397B |
| June 30, 2016 | 411.00M |
| March 31, 2016 | -386.00M |
| December 31, 2015 | 611.00M |
| September 30, 2015 | 524.00M |
| June 30, 2015 | 71.00M |
| March 31, 2015 | 626.00M |
| December 31, 2014 | 572.00M |
| September 30, 2014 | 903.00M |
| June 30, 2014 | 1.056B |
| March 31, 2014 | 617.00M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Johnson & Johnson | 8.616B |
| Eli Lilly & Co. | 10.69B |
| Merck & Co., Inc. | 5.37B |
| Pfizer Inc. | 835.00M |
| AstraZeneca PLC | 3.420B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -1.614B |
| Cash from Financing (Quarterly) | -2.63B |
| Free Cash Flow | 11.44B |
| Free Cash Flow Per Share (Quarterly) | 1.508 |
| Free Cash Flow to Equity (Quarterly) | 4.464B |
| Free Cash Flow to Firm (Quarterly) | 3.418B |
| Free Cash Flow Yield | 8.41% |